Global Autoimmune Disease Diagnostics Market Report By Type (Localized Autoimmune Disease Diagnostic, Systemic Autoimmune Disease Diagnostic), By Product (Drugs, Therapeutic & Monitoring Equipment, Diagnostic Equipment), By Technology (Bridge Therapy, Disease-modifying Antirheumatic Drugs (DMARD), Topical Therapy, Phototherapy, Helminthic Therapy, Recombinant Technology) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11214429
March 2021
Report Formats:
The global demand for Autoimmune Disease Diagnostics Market is presumed to reach the market size of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period 2021 - 2027.

The immune system offers protection to the body from many bacterial, viral infections, and other diseases. The autoimmune disorder is an unusual immune response occurring in the body. Autoimmune diseases reduce the body's ability to fight with the foreign particles resulting in attacking own body's tissues. The autoimmune disease is more common in women than men. Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus are some examples of autoimmune diseases. There are many tests commercially available at several healthcare centers to diagnose autoimmune disorders.

Market Dynamics

The global autoimmune disease diagnostics market is expected to grow due to increased government funding, a collaboration of clinics and diagnostics centers. In addition to this, the rise in the incidence of diseases such as rheumatoid arthritis, Graves, and Hashimoto's thyroid disease drives the growth of the market. Further, awareness about the various autoimmune diseases, advancements in medical fields, improved laboratory techniques, and others are also propelling the demand. However, high chances of false-positive results and slow turnaround time for diagnostic test results may hamper the market growth. Moreover, the developments in an emerging market, advancement in novel biomarkers for the prognosis of diseases are likely to offer new opportunities in market growth.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of autoimmune disease diagnostics. The growth and trends of autoimmune disease diagnostics industry provide a holistic approach to this study. 

Market Segmentation

This section of the autoimmune disease diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Type
  • Localized Autoimmune Disease Diagnostic
  • Systemic Autoimmune Disease Diagnostic
By Product
  • Drugs
  • Therapeutic & Monitoring Equipment
  • Diagnostic Equipment
By Technology
  • Bridge Therapy
  • Disease-modifying Antirheumatic Drugs (DMARD)
  • Topical Therapy
  • Phototherapy
  • Helminthic Therapy
  • Recombinant Technology
Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Autoimmune Disease Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Autoimmune Disease Diagnostics Market Share by Region (Representative Graph)

Global Autoimmune Disease Diagnostics Market Share


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the autoimmune disease diagnostics market include AstraZeneca, F. Hoffmann-La Roche, Novartis AG, Pfizer Inc., Sanofi-aventis, Abbott Laboratories, Beckman Coulter Inc., Inova Diagnostics Inc., Bio-Rad Laboratories Inc., and Hemagen Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . AUTOIMMUNE DISEASE DIAGNOSTICS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Type
           3.7.2 By Product
           3.7.3 By Technology
           3.7.4 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Type
       6.4 Localized Autoimmune Disease Diagnostic Market by Regions
       6.5 Systemic Autoimmune Disease Diagnostic Market by Regions
 
7 . GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT
       7.1 Overview by Product
       7.2 Historical and Forecast Data
       7.3 Analysis by Product
       7.4 Drugs Market by Regions
       7.5 Therapeutic & Monitoring Equipment Market by Regions
       7.6 Diagnostic Equipment Market by Regions
 
8 . GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
       8.1 Overview by Technology
       8.2 Historical and Forecast Data
       8.3 Analysis by Technology
       8.4 Bridge Therapy Market by Regions
       8.5 Disease-modifying Antirheumatic Drugs (DMARD) Market by Regions
       8.6 Topical Therapy Market by Regions
       8.7 Phototherapy Market by Regions
       8.8 Helminthic Therapy Market by Regions
       8.9 Recombinant Technology Market by Regions
 
9 . GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview, Historic and Forecast Data
           9.3.2. North America By Segment
           9.3.3. North America By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview, Historic and Forecast Data
           9.4.2. Europe by Segment
           9.4.3. Europe by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview, Historic and Forecast Data
           9.5.2. Asia Pacific by Segment
           9.5.3. Asia Pacific by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview, Historic and Forecast Data
           9.6.2. Latin America by Segment
           9.6.3. Latin America by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview, Historic and Forecast Data
           9.7.2. Middle East & Africa by Segment
           9.7.3. Middle East & Africa by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE AUTOIMMUNE DISEASE DIAGNOSTICS COMPANIES
       10.1. Autoimmune Disease Diagnostics Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF AUTOIMMUNE DISEASE DIAGNOSTICS INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. AstraZeneca
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. F. Hoffmann-La Roche
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Novartis AG
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Pfizer Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Sanofi-aventis
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Abbott Laboratories
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Beckman Coulter Inc.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Inova Diagnostics Inc.
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Bio-Rad Laboratories Inc.
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Hemagen Diagnostics Inc.
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Type (USD MN)
  • Localized Autoimmune Disease Diagnostic Market by Geography (USD MN)
  • Systemic Autoimmune Disease Diagnostic Market by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Drugs Market by Geography (USD MN)
  • Therapeutic & Monitoring Equipment Market by Geography (USD MN)
  • Diagnostic Equipment Market by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Bridge Therapy Market by Geography (USD MN)
  • Disease-modifying Antirheumatic Drugs (DMARD) Market by Geography (USD MN)
  • Topical Therapy Market by Geography (USD MN)
  • Phototherapy Market by Geography (USD MN)
  • Helminthic Therapy Market by Geography (USD MN)
  • Recombinant Technology Market by Geography (USD MN)
  • Global Autoimmune Disease Diagnostics Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Autoimmune Disease Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Autoimmune Disease Diagnostics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Localized Autoimmune Disease Diagnostic Market by Geography (USD MN)
  • Systemic Autoimmune Disease Diagnostic Market by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Drugs Market by Geography (USD MN)
  • Therapeutic & Monitoring Equipment Market by Geography (USD MN)
  • Diagnostic Equipment Market by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Bridge Therapy Market by Geography (USD MN)
  • Disease-modifying Antirheumatic Drugs (DMARD) Market by Geography (USD MN)
  • Topical Therapy Market by Geography (USD MN)
  • Phototherapy Market by Geography (USD MN)
  • Helminthic Therapy Market by Geography (USD MN)
  • Recombinant Technology Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials